Development of New Ti-Mn-Mo Alloys for Use in Biomedical Applications
Development of New Ti-Mn-Mo Alloys for Use in Biomedical Applications
复制标题
开发用于生物医学应用的新型 Ti-Mn-Mo 合金
DOI:
10.1002/9781119296126.ch293
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Huihong Liu
中科院分区:
文献类型:
--
作者:
Pedro Santos;Mitsuo Niinomi;Ken Cho;Masaaki Nakai;Huihong Liu
Titanium and its alloys are some of the standard metallic biomaterials used for implants due to their excellent biocompatibility in both mechanical and biochemical aspects. However, commercially pure titanium (CP‐Ti) shows comparatively low mechanical strength and widely used alloys, such as Ti‐6Al‐4V ELI (Ti‐64 ELI), can release harmful metallic ions in the human body (such as vanadium), which may cause long‐term health problems. For such reasons, the development of new alloys is necessary. In previous studies, manganese was used as an alloying element due to its better cytocompatibility and beta‐stabilizing effect. However, the low elongation to fracture of Ti‐Mn alloys requires to be improved. For this reason, molybdenum, was added as a third alloying element, to promote the formation of twins and to improve the elongation of Ti‐Mn alloys. The Ti‐5Mn‐3Mo alloy exhibited a high elongation to fracture of 33%, attributed to substantial mechanical twinning during tensile deformation with an ultimate tensile strength (UTS) of 916 MPa. The Ti‐6Mn‐4Mo alloy, on the other hand, exhibited an UTS of 1123 MPa with an acceptable elongation to fracture of 10%. In terms of the evaluated parameters, the Ti‐Mn‐Mo alloys studied show more suitable values than other alloys currently available for biomedical applications.